Spanakis, Emmanuel
Bristol-Myers Squibb (Switzerland)
2 papers on CoChatORCID 0000-0002-5107-8444
Most cited papers
- Verified
TEAD Inhibitors Sensitize KRASG12C Inhibitors via Dual Cell Cycle Arrest in KRASG12C-Mutant NSCLC
Tammaccaro, S. L., Prigent, P., Le Bail, J.-C., Dos-Santos, O., Dassencourt, L., Eskandar, M., Buzy, A., Venier, O., Guillemot, J.-C., Veeranagouda, Y., et al. (2023) · Pharmaceuticals
Hippo pathway signaling and YAP/TAZLung Cancer Treatments and Mutations
Cited by 18
- Verified
LBA1 Second-line adagrasib plus cetuximab vs chemotherapy in patients with KRASG12C-mutated metastatic colorectal cancer: Results from the KRYSTAL-10 trial
Tabernero, J., Kopetz, S., Lee, J., Corcoran, R. B., Hecht, J. R., Shen, L., Lonardi, S., Chen, Y., Fuang, H. G., Chen, Z., et al. (2026) · Annals of Oncology
Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments
Cited by 4
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free